Methylnitrosourea

CAS No. 684-93-5

Methylnitrosourea( —— )

Catalog No. M19334 CAS No. 684-93-5

N-Nitroso-N-methylurea is a nitrosourea compound with alkylating, carcinogenic, and mutagenic properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 61 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Methylnitrosourea
  • Note
    Research use only, not for human use.
  • Brief Description
    N-Nitroso-N-methylurea is a nitrosourea compound with alkylating, carcinogenic, and mutagenic properties.
  • Description
    N-Nitroso-N-methylurea is a nitrosourea compound with alkylating, carcinogenic, and mutagenic properties.
  • In Vitro
    N-Nitroso-N-methylurea (NMU; 5 μM) treatment increases the cellular NF-κB activity in human malignant keratinocytes. N-Nitroso-N-methylurea also increases the amount of I-κBα phosphorylation.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    684-93-5
  • Formula Weight
    103.08
  • Molecular Formula
    C2H5N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (2425.30 mM)
  • SMILES
    NC(=O)N(C)N=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yoshizawa K, et al. Caspase-3 inhibitor rescues N -methyl- N -nitrosourea-induced retinal degeneration in Sprague-Dawley rats. Exp Eye Res. 2000 Dec;71(6):629-35.
molnova catalog
related products
  • Alternariol-trimethy...

    The media of Alternaria alternata strain 261.

  • Dipotassium glycyrrh...

    Dipotassium glycyrrhizinate is an anionic surfactant having anti-allergic and anti-inflammatory activities.

  • MM-102 TFA

    MM-102 TFA is a potent WDR5/MLL interaction inhibitor, achieves IC50 = 2.4 nM.?MM-102 compound prevents the interaction between mixed lineage leukemia 1 (MLL1) and WD Trp-Asp repeat domain 5 (WDR5) and results in the inhibition of MLL1 H3K4 histone methyltransferase (HMT) activity.